The neglected burden of chronic hypoxia on the resistance of glioblastoma multiforme to first-line therapies
Abstract Glioblastoma multiforme (GBM) is the most common adult primary brain tumor. The standard of care involves maximal surgery followed by radiotherapy and concomitant chemotherapy with temozolomide (TMZ), in addition to adjuvant TMZ. However, the recurrence rate of GBM within 1–2 years post-dia...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2024-11-01
|
| סדרה: | BMC Biology |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12915-024-02075-w |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
